Current Perspectives in Ultra-sensitive Detection of Cancer-specific Biomarkers and Therapeutic Targets

Curr Cancer Drug Targets. 2023;23(11):829-833. doi: 10.2174/1568009623666230420152113.

Authors

Lyudmila V Savvateeva¹, Evgeni Yu Zernii², Andrey A Zamyatnin^{1

2

3

4}

Affiliations

¹ Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Moscow, 119991, Russia.
² Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119992, Russia.
³ Faculty of Health and Medical Sciences, University of Surrey, Guildford, GU2 7X, UK.
⁴ Department of Biotechnology, Sirius University of Science and Technology, Moscow, Russia.

PMID: 37078580
DOI: 10.2174/1568009623666230420152113

No abstract available

Keywords: Biomarkers; cancer-retina antigens; immunoassay; target molecules; therapeutics; ultra-sensitive assay.

Publication types

Research Support, Non-U.S. Gov't
Editorial

MeSH terms

Biomarkers
Biomarkers, Tumor* / genetics
Humans
Neoplasms* / diagnosis
Neoplasms* / drug therapy

Substances

Biomarkers, Tumor
Biomarkers